Champlain Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Champlain Investment Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-559,645	Closed	-$19.9M	–	127
2018 Q1	$19.9M	Sell	559,645 -33,350	-6%	-$1.31M	0.21%	111
2017 Q4	$25.9M	Buy	592,995 +117,145	+25%	+$5.47M	0.29%	100
2017 Q3	$24.9M	Buy	475,850 +19,905	+4%	+$1.11M	0.29%	100
2017 Q2	$26.7M	Buy	+455,945	New	+$23.7M	0.33%	99

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Champlain Investment Partners's SYNH Position: Q2 2018 in Review

Champlain Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2018, closing a stake of 559,645 shares — an estimated $19.9M sold.

Champlain Investment Partners first reported a position in SYNH in Q2 2017 and held it in 4 quarters. The position peaked at $26.7M in Q2 2017. 213 funds tracked by Wall St. Rank hold SYNH as of Q2 2018.

Champlain Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2018 after selling out during the quarter.
Champlain Investment Partners sold 559,645 Syneos Health, Inc. Class A Common Stock shares in Q2 2018, an estimated $19.9M.
Champlain Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 4 quarters.
Champlain Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $26.7M in Q2 2017.
213 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2018.

Based on Champlain Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.